Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a new version label reflecting a release update from v3.6.4 to v3.6.5. This update does not modify the study details or visible content.SummaryDifference0.5%

- Check16 days agoChange DetectedNo additions or deletions were provided in the changes block. The page content remains unchanged in this context.SummaryDifference0.4%

- Check24 days agoChange DetectedThe revision label on the page was updated to v3.6.4 from v3.6.3, representing a software version bump. It does not modify the study information or visible content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page’s revision indicator was updated to v3.6.3, replacing the previous v3.6.2 to reflect a new page version.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision label now shows v3.6.2, replacing v3.6.0. This indicates an updated page version, typically reflecting minor updates or corrections.SummaryDifference0.0%

- Check66 days agoChange DetectedThe study record gains new guidance and navigation sections to help readers understand the study and how to participate, including a recruitment update indicating enrollment is closed. The Intervention/Treatment header formatting has been changed, and a site revision notice (Revision: v3.6.0) was added.SummaryDifference0.4%

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.